Agilent 13. Feb. 2026 FDA Ovarian Cancer Nod Puts Focus On Agilent Valuation And Momentum - simplywall.st FDA Ovarian Cancer Nod Puts Focus On Agilent Valuation And Momentum - simplywall.st Original